Serotonin depletion amplifies distinct human social emotions as a function of individual differences in personality by Kanen, Jonathan W. et al.
Kanen et al. Translational Psychiatry           (2021) 11:81 
https://doi.org/10.1038/s41398-020-00880-9 Translational Psychiatry
ART ICLE Open Ac ce s s
Serotonin depletion amplifies distinct human social
emotions as a function of individual differences in
personality
Jonathan W. Kanen 1,2, Fréderique E. Arntz1,2,3, Robyn Yellowlees1,2,4, Rudolf N. Cardinal 2,5,6, Annabel Price5,6,
David M. Christmas5,6, Annemieke M. Apergis-Schoute2,7, Barbara J. Sahakian2,5 and Trevor W. Robbins 1,2
Abstract
Serotonin is involved in a wide range of mental capacities essential for navigating the social world, including emotion
and impulse control. Much recent work on serotonin and social functioning has focused on decision-making. Here we
investigated the influence of serotonin on human emotional reactions to social conflict. We used a novel
computerised task that required mentally simulating social situations involving unjust harm and found that depleting
the serotonin precursor tryptophan—in a double-blind randomised placebo-controlled design—enhanced emotional
responses to the scenarios in a large sample of healthy volunteers (n= 73), and interacted with individual differences
in trait personality to produce distinctive human emotions. Whereas guilt was preferentially elevated in highly
empathic participants, annoyance was potentiated in those high in trait psychopathy, with medium to large effect
sizes. Our findings show how individual differences in personality, when combined with fluctuations of serotonin, may
produce diverse emotional phenotypes. This has implications for understanding vulnerability to psychopathology,
determining who may be more sensitive to serotonin-modulating treatments, and casts new light on the functions of
serotonin in emotional processing.
Introduction
A unified function for serotonin (5-hydroxytryptamine;
5-HT) has, perhaps unsurprisingly, proven to be elusive. It
is hypothesised to have a role in many psychiatric dis-
orders1, and is implicated in a wide range of mental
functions including aversive processing, impulse control
and social behaviour2. These domains can be viewed
under a unified framework by considering how serotonin
impacts Pavlovian (stimulus-outcome, including emo-
tional) and instrumental (stimulus-response-outcome;
operant) processes that underlie both social and nonsocial
functions3. Much recent work on the relationship
between serotonin, aversive processing and human social
behaviour has focused on instrumental action in the
context of behavioural economic games and moral
dilemmas4–6. Here we examined emotional reactions to
social scenarios depicting unjust harm.
Studies of healthy volunteers have primarily employed
two techniques to investigate serotonin function: acute
tryptophan depletion (ATD), a dietary technique that
temporarily lowers brain serotonin levels by depleting its
biosynthetic precursor, tryptophan7–11 and treatment
with single doses of selective serotonin reuptake inhibitors
(SSRIs). SSRIs are generally assumed to increase extra-
cellular serotonin; however, it should be noted that single
rather than chronic doses can paradoxically decrease
serotonin in projection areas2,12. ATD studies have
revealed disinhibition of retaliatory behaviour in the face
of perceived injustice4, modelled using the Ultimatum
Game (UG), while single-dose SSRI has had prosocial
effects5.
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Morally relevant social emotions, meanwhile, lie at the
interface between moral standards and socially appro-
priate behaviour13. Moral standards prohibit behaviours
that are likely to have negative consequences for the well-
being of others. Emotions are in part Pavlovian in nature,
and while ATD has been shown to modulate Pavlovian
processes in nonsocial domains14,15, here we tested the
influence of ATD on emotion in a social context. We
asked whether ATD would enhance morally relevant
negative emotions evoked by social scenarios in which a
person was unjustly harmed: these served as Pavlovian
cues. Using a novel task, we prompted participants to
reflect on the situations and specifically assessed emotions
involving annoyance, guilt, shame and feeling “bad”.
Reporting one’s emotional reactions after mentally
simulating hypothetical social scenarios implicitly calls on
autobiographical memories, which should result in a
diversity of subjective experiences tied to personal quali-
ties and expectations about social behaviour. We there-
fore also tested the influence of three personality traits—
empathy, psychopathy and impulsivity—on how serotonin
would affect emotion.
Research on moral emotions has focused mostly on the
self-conscious negative-emotions guilt and shame13. Guilt
often relates to a negative appraisal of a specific beha-
viour, whereas shame tends to involve a negative evalua-
tion of the self:13 “If only I hadn’t” as opposed to “If only I
weren’t”16. While guilt is part of the diagnostic criteria for
depression17, proneness to shame most consistently
relates to an array of psychiatric conditions, including
symptoms of depression18–20, anxiety19, post-traumatic
stress disorder21–24 and eating disorders25,26, as well as
more specific symptoms such as low self-esteem27, suici-
dal ideation28, anger29,30 and aggression30. Importantly,
guilt is thought to become maladaptive primarily when it
is fused with shame13.
Evidence from patients with damage to the ven-
tromedial prefrontal cortex (vmPFC) and incarcerated
individuals with psychopathy provides a plausible con-
nection between moral emotions and social behaviour.
The vmPFC is an area central to emotion regulation31,
with dense serotonergic innervation32. Individuals with
vmPFC damage also show increased retaliatory behaviour
to unfairness on the UG33, which mirrors the ATD find-
ings4,6. This is furthermore analogous to the UG results
from psychopathic individuals34, where vmPFC dysfunc-
tion is a feature35, as is reduced guilt36. Impaired moral
behaviour following damage to the vmPFC has meanwhile
been conceptualised as a manifestation of diminished
guilt37. The implication here is that guilt is related to
inhibition of antisocial behaviour, as modelled by restraint
in behavioural economic games like the UG. Studying the
effects of ATD on guilt could therefore inform how moral
emotion and behaviour are integrated.
Proneness to guilt consistently correlates with empathy,
which refers to the ability to share the affective experi-
ences of others13. Empathy, while not a discrete emotion,
is a morally relevant emotional capacity13 and trait38.
Guilt appears to foster reparative action, promote empa-
thy13 and increase altruistic acts39. Elevated empathy,
moreover, has been correlated with severity of depression,
and proposed as a risk factor for its development40.
Importantly, empathy is classically absent in
psychopathy41.
We were especially interested in empathy because moral
decision-making in individuals high in trait empathy has
been shown to be particularly sensitive to manipulations
of serotonin5. Furthermore, the serotonin 2 A (5-HT2A)
receptor agonists lysergic acid diethylamide (LSD), psilo-
cybin, and 3,4-methylenedioxymethamphetamine
(MDMA), have all been shown to enhance empathy42–44.
To extend these findings we therefore tested the
hypothesis that ATD would interact with trait empathy to
amplify morally relevant social emotion. Given the con-
sistent correlations between guilt-proneness and empa-
thy13, we predicted guilt would be the most likely emotion
to be affected.
Conversely, psychopathy is characterised by emotional
dysfunction reflected in reduced guilt and empathy45, and
an increased risk for aggression. Aggression can be either
goal-directed (e.g. a premeditated crime), or reactive: an
explosive, impulsive response to frustration36. Many
psychiatric conditions increase the risk for reactive
aggression, however psychopathy is unique in that there is
an increased risk for both reactive and goal-directed
aggression36. Aggression is in turn traditionally associated
with low serotonin46, including evidence from studies of
violent offenders47. We explored whether psychopathic
traits are likewise related to morally relevant emotions,
and whether ATD modulates this relationship. We pre-
dicted that psychopathic traits might have the most pro-
nounced effect on feeling annoyed, which invokes the
notion of frustration.
While some, but not all, aggression can be impulsive,
aggression and impulsivity are distinct. Indeed, discrete
serotonergic circuits modulate aggressive versus impul-
sive behaviour in mice48. ATD can induce “waiting
impulsivity” (diminished action restraint while waiting for
a reward) and “impulsive choice” (accepting small
immediate rewards over larger delayed ones) in healthy
individuals6,49. More impulsive choice has been correlated
with increased aggressive impulses to perceived injustice
on the UG, which was heightened further by ATD6. We
therefore asked whether trait impulsivity on the Barratt
Impulsiveness Scale50 was related to increased annoyance
following ATD.
To test our hypotheses, we employed ATD in a double-
blind, randomised, placebo-controlled, between-groups
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design, in healthy volunteers. We predicted that ATD
would enhance negative emotion overall, and that indi-
vidual differences in empathy, psychopathy, and impul-
sivity would influence how ATD modulated the profile of
emotion. In line with the traditional disconnection
between psychopathy and empathy, we predicted that
there would be dissociation between how trait empathy
and psychopathy interact with neurochemical status to
modulate annoyance, guilt, shame and feeling bad. Given
the established connection between serotonin and
impulsivity49,51,52, and retaliatory behaviour6, we also
hypothesised that high-trait impulsivity would be related
to increased feelings of annoyance, which would be fur-
ther potentiated by ATD in these individuals.
Materials and methods
Participants
Seventy-three healthy participants (mean age 24.6, 39
males) completed the experiment. Participants were
medically healthy and screened to be free from any psy-
chiatric disorders, using the Mini-International Neu-
ropsychiatric Interview53. Individuals who reported,
during screening, having a first-degree relative (parent or
sibling) with a psychiatric disorder were also excluded.
Other exclusion criteria included neurological disorders,
current use of any regular medication excluding contra-
ceptive pills, and past use of neurological or psychiatric
medication. Further exclusion criteria and measures to
ensure a matching of the groups are reported in the
Results and Supplementary Material. Participants gave
informed consent before the start of the study and were
paid for their participation.
General procedure
The protocol was approved by the Cambridge Central
Research Ethics Committee (16/EE/0101), and the study took
place at the National Institute for Health Research/Wellcome
Trust Clinical Research Facility at Addenbrooke’s Hospital in
Cambridge, England. Participants arrived in the morning of
the study day having fasted for at least 9 h beforehand and
completed a baseline 16-item visual analogue scale (VAS) to
assess mood and other feelings including alertness. The VAS
was also completed during the middle and end of the day.
Participants then gave a baseline blood sample, and ingested
either a placebo or tryptophan depletion drink. Simple ran-
domization was employed. In the afternoon, participants
gave a second blood sample, ~4.5 h after ingesting the drink.
The Moral Emotions task (described below) was adminis-
tered following the nadir of plasma tryptophan levels, which
has been reported to occur in the sixth hour after consuming
the amino-acid mixture54. Other tasks that will be reported
elsewhere preceded the Moral Emotions task in the following
order and examined: behavioural attributions55, probabilistic
reversal learning56, theory of mind57, Pavlovian
conditioning58, avoidance learning59 and deterministic
reversal learning. The administration of multiple tasks within
a single ATD study is a common approach taken by several
studies cited within this manuscript4,6,14,49,60. Participants
additionally attended a short afternoon session the day
before, with no pharmacological manipulation, where they
completed baseline questionnaires and three unrelated tasks,
which will not be reported here. The present laboratory
experiment was conducted once.
Acute tryptophan depletion
Tryptophan is the amino-acid precursor necessary to
synthesize brain serotonin. Acute tryptophan depletion
(ATD) is a widely used dietary manipulation, which
results in a rapid decrease in the synthesis and release of
serotonin7–11. Participants were randomly assigned to
receive either ATD or a placebo condition, in a double-
blind, between-groups design. The depletion group
received a drink that contained a balance of all the
essential amino acids except for tryptophan. The placebo
group received the same drink except that it included
tryptophan. Blood plasma samples were collected to verify
depletion and analysed using high performance liquid
chromatography (HPLC).
Moral emotions task
We employed a novel task, part of the EMOTICOM
neuropsychological testing battery57,61, to measure feelings of
guilt, shame, annoyance and feeling “bad”. Using a touchsc-
reen computer, participants were presented with cartoons of
social scenarios—Pavlovian cues—in which someone was
unjustly harmed, either intentionally or unintentionally. We
then interrogated emotional reactions to these scenarios by
asking participants to reflect, and report how they would feel
if they were the victim or agent of harm. An example of one
trial is depicted in Fig. 1. There were 28 randomised trials,
composed of 14 different cartoons, which were each pre-
sented twice—once where participants were prompted to
identify as the victim, and once where they were asked to
identify as the agent. The specific instruction was, “If this was
you, please indicate below how you would feel by touching
the line.” The four different emotions were measured using
four unnumbered touchscreen scales, with seven rungs to
choose from, where the first rung was labelled “not at all”,
scored as 1, and the seventh labelled “extremely”, scored as 7.
Half of the scenarios involved an intentional harm. In the
other half, the harm committed was accidental. The task was
self-paced.
Statistics
Sample size was chosen based on a recent analogous
study that also employed the EMOTICOM neu-
ropsychological testing battery, in healthy volunteers, and
using a serotonergic manipulation62. Data were analysed
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using MATLAB (MathWorks) and SPSS (IBM).
MATLAB code is available as supplementary material. All
statistical tests were two-sided. Homogeneity of variance
in t-tests was verified with Levene’s test, and degrees of
freedom were adjusted when this assumption was vio-
lated. The Greenhouse–Geisser correction was used
where applicable, in designs with within-subjects factors,
to correct for violation of the sphericity assumption as
determined by Mauchly’s test. Adjustments for multiple
comparisons were not deemed necessary.
Results
Seventy-three participants completed the study: 37
underwent depletion (20 males), while the remaining 36
received placebo (19 males).
Effects of ATD on mood ratings
Mood ratings were unaffected by ATD. We collected
rating data from 65 participants (n= 33 depletion) on
how happy or sad they were feeling before the task, after
depletion had taken effect, and these ratings did not differ
from those of participants in the placebo group (t(63)=
−0.727, p= 0.47). There were also no baseline differences
in depressive symptoms (t(71)=−1.258, p= 0.212) using
the Beck Depression Inventory-II63.
How serotonin depletion modulates emotional ratings
overall
We tested whether serotonin depletion potentiated
emotions overall, irrespective of individual differences. To
do this we performed repeated measures analysis of var-
iance (ANOVA) incorporating all four emotions mea-
sured. Serotonin status (ATD versus placebo) was the
between-subjects factor, and the within-subjects factors
were emotion (annoyance, guilt, shame, and feeling bad),
agency (agent or victim of harm) and intentionality
(intentional or unintentional harm). Indeed, serotonin
depletion potentiated emotion overall (F(1,71)= 5.959, p=
0.017, ηp
2= 0.077), shown in Table 1 and Supplementary
Fig. 1. There were highly significant main effects for
emotion (F(2,155)= 171.744, p= 7.4 × 10
−42, ηp
2= 0.708),
agency (F(1,71)= 630.212, p= 4.9 × 10
−37, ηp
2= 0.899)
and intentionality (F(1,71)= 11.799, p= 0.001, ηp
2=
0.143), regardless of serotonergic status, which supports
task validity and suggests individuals were attuned to the
social context of the scenarios. Emotional ratings were
significantly greater when imagining being the agent
compared to the victim, and when the harm committed
was intentional rather than unintentional. There were no
interactions between serotonin status and agency or
intentionality (all p > 0.05). Our core results in this study,
however, came from analyses of how individual differ-
ences interacted with the serotonin-depleted state to
modulate emotion, which now follow.
Correlations between trait measures
First, we ensured that our trait measures of interest
were not correlated with one another. Scores on the
impulsivity and psychopathy scales were not correlated
(r(73)=−0.113, p= 0.342). Empathy scores were likewise
Once you have finished reading, press any key to connue
If this was you, how would you feel?
Press any key to connue
If this was you, please indicate below 
how you would feel by touching the line
Guilty Ashamed
Annoyed





Fig. 1 Moral emotions task schematic57. Three example slides of a trial are shown. Feeling “bad” was assessed with a rating scale on a fourth slide.
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not correlated with impulsivity (r(73)= 0.094, p= 0.427)
or psychopathy (r(73)= 0.015, p= 0.897).
How trait empathy modulates emotional effects of
serotonin depletion
Given prior evidence that single-dose SSRI had a more
pronounced effect on social behaviour in highly empathic
participants5, a central question in our study was whether
the serotonin-depleted state and empathic trait interacted
to influence emotion. Indeed, we found that the self-
conscious emotion guilt was more sensitive to serotonin
depletion in individuals with high-trait empathy. We
ensured self-reported empathy at baseline, using the
Interpersonal Reactivity Index (IRI)38, was matched
between placebo and depletion (t(63)= 0.442, p= 0.660;
Levene’s test F(71)= 4.569, p= 0.036). We analysed emo-
tional ratings via analysis of covariance (ANCOVA), using
empathy and serotonin status (ATD versus placebo) as
factors in a between-subjects interaction term, controlling
for main effects, and agency (agent or victim) and intent
(intentional or unintentional) as within-subjects factors.
For guilt ratings, this revealed a significant four-way ser-
otonin × empathy × agency × intentionality interaction
(F(1,69)= 5.596, p= 0.021, ηp
2= 0.075). Guilt ratings were
significantly higher in more empathic individuals follow-
ing serotonin depletion (r(37)= 0.385, p= 0.019), and not
under placebo (r(36)= 0.265, p= 0.118), irrespective of
agency or intentionality, seen in Fig. 2a and Table 1.
Follow-up tests showed that the agency and intentionality
effect was driven by a highly significant relationship
between empathy and guilt, when imagining inflicting
(being the agent of) harm unintentionally (r(37)= 0.43,
p= 0.008). There was additionally a three-way interaction
between agency, intentionality and group (F(1,69)= 4.765,
p= 0.032, ηp
2= 0.065). Critically, however, this three-way
interaction disappeared when empathy was not included
as a factor in the (otherwise identical) model (F(1,71)=
0.608, p= 0.438, ηp
2= 0.008). We were also able to
reproduce this core result on guilt, using a quartiles
approach whereby individuals with an empathy score in
the top 25% were deemed “high empathy” and the bottom
25% “low empathy”. ANCOVA with empathy (high versus
Fig. 2 Effects of trait empathy on how serotonin depletion influences emotion. Shading indicates 1 standard error. Each point represents the
average emotion ratings for each individual, collapsed across agency and intentionality. a The highly empathic reported more guilt following
depletion relative to when on placebo. b Shame was significantly elevated in individuals high in trait empathy on both placebo and depletion.
Table 1 Summary of results on personality traits.
Annoyance Guilt Shame Bad
Placebo ATD Placebo ATD Placebo ATD Placebo ATD
Impulsivity −
Psychopathy ↑↑
Empathy ↑↑ + +
Arrows (↑↑) indicate a significant enhancement of the emotion by ATD at high levels of the personality trait shown; Plus sign (+) indicates a significant positive
relationship between the personality trait and the emotion that was not significantly modulated by ATD; Minus sign (−) likewise indicates a significant negative
relationship. Emotions are collapsed across agency and intentionality.
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low) and serotonin status (ATD versus placebo) as factors
in a between-subjects interaction term, controlling for
main effects, and agency (agent or victim) and intent
(intentional or unintentional) as within-subjects factors,
again revealed a significant four-way serotonin × empa-
thy × agency × intentionality interaction effect on guilt
(F(1,36)= 7.028, p= 0.012, ηp
2= 0.163). While the
ANCOVA approach, as above, did not yield a significant
interaction of serotonin and empathy on shame (F < 0.42,
p > 0.05, ηp
2 < 0.007 for all terms involving serotonin
status), empathy and overall shame ratings were highly
correlated in both the depletion (r(37)= 0.437, p= 0.007)
and placebo groups (r(36)= 0.425, p= 0.01). These data
for shame are shown in Fig. 2b and Table 1. The
ANCOVA on annoyance was not significant (F < 2, p >
0.05, ηp
2 < 0.03 for all terms involving serotonin status), as
was the case for the ANCOVA on feeling “bad” (F < 1.2,
p > 0.05, ηp
2= 0.02 for all terms involving serotonin sta-
tus). Guilt, therefore, was uniquely affected by the inter-
action between trait empathy and the serotonin-depleted
state. Serotonin induced a distinct emotional profile in
highly empathic individuals.
How trait psychopathy modulates emotional effects of
serotonin depletion
Trait psychopathy also interacted with the serotonin-
depleted state to modulate emotion. We ensured psy-
chopathic traits assessed with the Levenson Self-Report
Psychopathy Scale64 at baseline were matched in the
placebo and depletion groups (t(71)= 1.132, p= 0.261).
ANCOVA with serotonin status (ATD versus placebo)
and psychopathy as factors in a between-subjects inter-
action term, controlling for main effects, and agency and
intentionality as within-subjects factors revealed a sig-
nificant serotonin × psychopathy × intentionality three-
way interaction for feelings of annoyance (F(1,69)= 7.172,
p= 0.009, ηp
2= 0.094). With increasing trait psycho-
pathy, individuals felt even more annoyed following ser-
otonin depletion, seen in Fig. 3a and Table 1.
Intentionality significantly interacted with psychopathy to
influence annoyance under placebo (F(1,34)= 5.163, p=
0.03, ηp
2= 0.132) and not following depletion (F(1,34)=
2.237, p= 0.144, ηp
2= 0.06). In other words, the influence
of psychopathy on annoyance depended on intentionality
when on placebo, but on depletion those high in trait
psychopathy were more annoyed regardless of intention-
ality. There was additionally a significant serotonin ×
intentionality interaction (F(1,69)= 7.161, p= 0.009, ηp
2=
0.094). Critically, however, this two-way interaction dis-
appeared when psychopathy was not included as a factor
in the (otherwise identical) model (F(1,71)= 0.043, p=
0.836, ηp
2= 0.001). Next, we assessed guilt using the same
ANCOVA approach: there was no serotonin × psycho-
pathy interaction (F(1,69) < 2.8, p > 0.05, ηp
2 < 0.04 for all
terms involving serotonin status). There was no ser-
otonin × psychopathy interaction for shame (F(1,69) < 3.8,
p > 0.05, ηp
2 < 0.055 for all terms involving serotonin
status) nor for feeling bad (F(1,69) < 2.1, p > 0.05, ηp
2 < 0.03
for all terms involving serotonin status).
Trait impulsivity and emotional effects of serotonin
depletion
Trait impulsivity, measured at baseline with the Barratt
Impulsiveness Scale50, was also matched between groups,
and did not interact with the serotonin-depleted state to
modulate emotion. Data on impulsivity are summarised in
Fig. 3 Effects of trait psychopathy and impulsivity on emotional effects of serotonin depletion. Shading indicates 1 standard error. Each point
represents the average emotion ratings for each individual, collapsed across agency and intentionality. a Annoyance was potentiated by serotonin
depletion in high-trait psychopathy. b Trait impulsivity did not significantly enhance the effects of ATD on annoyance.
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Table 1. First, we assessed feelings of annoyance using
ANCOVA with serotonin status (ATD versus placebo)
and impulsivity as factors in a between-subjects interac-
tion term, controlling for main effects, and agency (agent
or victim) and intent (intentional or unintentional) as
within-subjects factors: there was no interaction between
serotonin and impulsivity (F(1,69) < 1.7, p > 0.05, ηp
2 <
0.025 for all terms involving serotonin status). These data
are shown in Fig. 3b. The same was true for all terms
involving serotonin status in the ANCOVAs on guilt
(F(1,69) < 0.7, p > 0.05, ηp
2 < 0.01), shame (F(1,69) < 0.4, p >
0.05, ηp




We also explored whether there was any structure
underlying the task measurements that was not detected
by our prior analyses. To do this, we used principal
components analysis (PCA) on the 16 outcome variables
from the task (see Supplementary for methods; factor
loadings are shown in Supplementary Table 1). The
validity of this PCA was confirmed by comparing the
number of components, and the variables that clustered
together, to a PCA on the same task in the original larger
dataset from a non-pharmacological study of 186 healthy
participants57. We then interpreted how the task mea-
surements from our experiment clustered into the four
principal components. Component 1 centred on annoy-
ance with others for having done harm to oneself—in
other words, outward frustration. The predominant
theme of component 2 was inward frustration, or
annoyance with oneself for having harmed another.
Components 3 and 4 centred on the self-conscious
negative-emotions guilt and shame. Component 3 cap-
tured these emotions when the participant was the agent,
component 4 when the participant was the victim of
harm. We then used the estimated factor scores for each
individual to assess how serotonin depletion modulated
the constructs captured by the four components. ANOVA
with serotonin status (ATD versus placebo) as a between-
subjects factor, and the four components as levels of a
within-subjects factor, revealed a significant serotonin ×
component interaction (F(3,213)= 3.165, p= 0.025, ηp
2=
0.043). There was no main effect of serotonin depletion
(F(1,71)= 2.187, p= 0.144, ηp
2= 0.030). Follow-up t-tests
revealed the values of component 2 (t(71)= 2.124, p=
0.037) and component 4 (t(71)= 2.290, p= 0.025) were
each significantly greater following depletion relative to
placebo, as seen in Supplementary Fig. 2. Inward frus-
tration, or annoyance, for having harmed another—cap-
tured by component 2—was potentiated by serotonin
depletion. When the victim of harm in the task, self-
conscious negative emotion was also exacerbated by ser-
otonin depletion (component 4).
Blood analysis
Blood results are shown in Fig. 4. The ratio of trypto-
phan to large neutral amino acids (TRP:LNAAs; trypto-
phan to valine, methionine, isoleucine, leucine, tyrosine
and phenylalanine) was calculated, as this is thought to be
most reflective of the extent of brain serotonin deple-
tion65. We then performed a t-test on the change in the
TRP:LNAA ratio between samples taken at baseline and
approximately 4.5 h following administration of the mix-
ture. Plasma levels were unavailable for two participants:
one due to a staff processing error, and one due to diffi-
culty with venepuncture. We achieved a robust depletion
of tryptophan (t(60)=−19.163, p= 3.01 × 10
−27).
Correlation analyses
Extent of depletion was not correlated with any parti-
cular emotion, reinforcing the importance of accounting
for traits to uncover effects of ATD on social emotion.
Change in TRP:LNAA ratio was not correlated with
annoyance (r=−0.208, p= 0.081), guilt (r=−0.121, p=
0.314), shame (r=−0.057, p= 0.636), or feeling bad (r=
−0.088, p= 0.464). There were correlations between
emotion ratings: collapsed across serotonergic status,
annoyance, guilt, and shame were all positively correlated
with one another (p < 0.05), consistent with the non-
specific enhancement of emotion in the absence of con-
sidering traits. Guilt and shame were both negatively
correlated with feeling bad (p < 0.05). These correlations,
with exact p-values and correlation coefficients, are pre-
sented in Supplementary Table 2.
Summary of results
Results are summarised in Table 1. Serotonin depletion
enhanced emotion overall. Examining individual trait
differences revealed a deeper story. Guilt was significantly
enhanced by serotonin depletion in highly empathic
participants, which was a distinctive emotional profile.
Fig. 4 Blood analysis results. Error bars represent 1 standard error.
Significance at p < 5 ×10−27 is denoted by #####. n.s. denotes not
significant.
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This was driven by guilt when the agent of an uninten-
tional harm. Trait empathy, furthermore, was highly
correlated with shame ratings in both the placebo and
depletion groups. Greater trait psychopathy following
serotonin depletion, meanwhile, was associated with
enhancement of annoyance. PCA revealed a component
where guilt and shame clustered together when the victim
of harm, which was potentiated by ATD.
Discussion
Using a novel test that cued autobiographical memories,
we showed that serotonin depletion heightened emotional
reactions when mentally simulating social scenarios
involving unjust harm. While emotion was enhanced
nonspecifically at the group level, harnessing baseline
individual differences revealed that personality traits play
a critical role in shaping which distinctive types of emo-
tions are affected by serotonin depletion. A key result was
that individuals high in trait empathy showed a distinct
profile of enhanced guilt following serotonin depletion.
This contrasted with how variation in trait psychopathy
(classically associated with lack of empathy and guilt)
influenced the relationship between serotonin depletion
and emotional reactions: only annoyance was potentiated.
This dissociation, in other words, mirrored the antitheti-
cal nature of empathy and psychopathy. Previous studies
have shown that traits can influence the magnitude of
effects of serotonin manipulations on social behaviour;5,6
we now show that traits modulated the quality, as well as
the magnitude, of social emotion following serotonin
depletion. Traits contribute to an individual’s model of
the world, and therefore shape prior expectations about
social interactions: we propose the influence of traits on
how serotonin modulated emotions can be thought of as
constituting biological “priors”.
Emotions prepare the body for action or inaction66. Our
findings on the serotonergic modulation of social emotion
converge with the literature on social decision-making,
and we propose that our results represent a Pavlovian
influence that can shape social behaviour3. The deploy-
ment of empathy has additionally been described as
having a Pavlovian character, which can shape behaviour
triggered by cues signalling harm3. While we did not
measure behaviour, there are some intriguing parallels
between our findings on emotional reactions to unjust
harm, and studies of retaliatory behaviour to unfairness,
as assessed using the Ultimatum Game4,6 which we
highlight below. In the UG, individuals must split a sum of
money with another, and are given the opportunity to
reject unfair offers, in which case neither player gets
paid4,6. Indeed, the UG has been studied under serotonin
depletion and in relation to empathy and psychopathy.
Empathy was of central importance to our analysis. This
was motivated by the observation that social behaviour in
highly empathic participants was especially sensitive to
single-dose SSRI administration: these individuals showed
the greatest reduction in retaliatory behaviour to unfair-
ness5. Critically, we found that individuals high in trait
empathy had a distinct profile of enhanced emotion: guilt
was amplified. Empathy and guilt are consistently corre-
lated13, and guilt may even promote empathy13. Feelings
of guilt have been associated with real-life altruistic acts39.
Guilt has been proposed to restrain antisocial behaviour
as modelled by laboratory tests: a diminished sense of
guilt is thought to contribute to dysfunctional social
behaviour following vmPFC damage37, and is also a fea-
ture of psychopathy36. The present observation that
increased guilt in the highly empathic under ATD was
driven by instances of unintentionally inflicting harm in a
social setting is entirely consistent with these accounts.
Shame, furthermore, was highly correlated with empa-
thy. This was true in both the placebo and depletion
conditions, which could have led to a ceiling effect, leav-
ing less room for further enhancement of shame by ATD
in the highly empathic, on top of an already elevated
baseline under placebo. Guilt and shame, moreover,
clustered together in the PCA when the victim of harm,
and this component was enhanced by serotonin depletion
regardless of personality traits. Guilt and shame are dis-
tinguishable yet can overlap13, which is also true of their
neural correlates67. While guilt and shame were corre-
lated, the literature indicates that different events can be
guilt-inducing or shame-inducing for different people13.
That different types of emotion were enhanced in tandem
at the group level, furthermore, does not imply the quality
of these emotions cannot be distinguished by the person
experiencing them.
Shame-free guilt is seen as possibly adaptive—for
instance by promoting reparations—while proneness to
shame is seen as a risk for, and is indeed associated with a
wide range of psychopathology13. Importantly, guilt is
thought to become maladaptive primarily when it is fused
with shame13. Guilt overlaid with shame is most likely a
source of rumination13. The hippocampus has been
reported to be involved in the experience of shame68, and
failure of hippocampal serotonin is suggested to con-
tribute to rumination69. SSRIs, meanwhile, improve hip-
pocampal function in depression70. Individuals with
hippocampal damage, moreover, appear to show heigh-
tened reactive emotionality congruent with their beha-
viour in moral decision-making tasks, which is antithetical
to the pattern seen with vmPFC lesions71. While the
relationship with our results is merely speculative, hip-
pocampal dysfunction is a feature of numerous psychiatric
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conditions, as is social dysfunction: a recent framework
proposes these two well-established phenomena can be
unified through the purported role of the hippocampus in
organising social information (memories), via relational
maps that support simulations of social outcomes72.
Indeed, there are reported links between elevated
empathy and depression40. Individuals sensitive to distress
in others may be more likely to experience personal dis-
tress, and this has been highlighted as a vulnerability
factor for depression39,40. At the same time, there is evi-
dence for diminished deployment of theory of mind—
non-affective perspective taking—in depression73, and
this combination raises the possibility that sensitivity to
distress in oneself and others may become misattributed
or inappropriately directed inward.
While mood was unaffected in our study, consistent
with the literature on ATD in healthy individuals74, ATD
can transiently reinstate low mood in depressed indivi-
duals successfully treated with an SSRI74. By using trait
measurements and a task that elicited emotions, however,
we were able to uncover a pattern reminiscent of
depression: more guilt in the highly empathic under ser-
otonin depletion. Indeed, this task has already been used
to detect possible latent vulnerabilities in a healthy
population with trait paranoia61. We propose that
empathy, which produced a qualitatively unique emo-
tional profile under ATD, may represent an important
proxy for sensitivity to changes in serotonin.
Conversely, psychopathic individuals classically have
impairments in guilt and empathy, and an increased risk
for aggressive behaviour, especially following frustra-
tion36,45. This is consonant with our results. We found
that the emotional profile following serotonin depletion in
healthy individuals high in psychopathic traits dissociated
from what we observed in the highly empathic: annoyance
was instead amplified following unjust harm. This result is
furthermore in line with existing literature on social
decision-making: clinically psychopathic individuals show
an analogous pattern of behaviour on the UG34 to the
disinhibited aggressive impulses seen in ATD studies of
healthy volunteers4, that is also quantitatively similar to
how individuals with vmPFC lesions behave on the UG34.
Critically, vmPFC damage is associated with impaired
emotion regulation, and individuals with such lesions tend
to exhibit anger and irritability particularly following
frustration in their personal lives33. Diminished structural
and functional connectivity between the vmPFC and
amygdala in clinically psychopathic individuals35 is indeed
thought to be a central mechanism underlying the con-
dition. Interactions between these structures are further-
more sensitive to ATD in healthy individuals viewing
facial signs of aggression60. That serotonin depletion
made participants high in trait psychopathy more
annoyed by social injustice may be relevant for
understanding how serotonin affects the emotional basis
of retaliatory behaviour to unfairness4,6. This view is
supported by work showing that such behavioural reac-
tions are associated with self-reported anger in healthy
volunteers75. Trait anger and psychopathy in violent
offenders indeed appears to reflect 5-HT1B receptor
levels76, which moreover fits with the vast literature
implicating serotonergic dysfunction in aggression46,51,77.
The individual differences we observed in response to a
challenge of brain serotonin are likely in part related to
the relative contribution of the multiple serotonin sub-
systems in the brain. Importantly, preferential dysfunction
in the median or dorsal raphe nuclei, which innervate,
among other regions, the hippocampus and prefrontal
cortex, respectively, has been putatively related to phe-
notypes as divergent as depression and antisocial per-
sonality disorder, respectively; both nuclei project to the
amygdala46. Recent data underscore the complexity of
serotonin subsystems, revealing that even within the
dorsal raphe there are subsystems that have distinct and at
times opposing functions: both activate to reward but
have opposing responses to aversion78.
A limitation of our experiment is we did not measure
serotonin (5-HT) directly: we measured plasma trypto-
phan levels following depletion, as tryptophan is the
amino-acid precursor of serotonin and ATD has been
shown to produce transient reductions in central ser-
otonin synthesis in humans11. While the validity of ATD
as a method to manipulate central serotonin has been
questioned79, this position has been rebutted on the basis
of considerable evidence9. Consonant results between
human studies employing ATD, and rodent experiments
that induce profound serotonin loss using the neurotoxin
5,7-dihydroxytryptamine (5,7-DHT), bolster the case that
ATD reduces central serotonin. A prime example comes
from studies of waiting impulsivity, which can be induced
in humans following ATD49, and in rats after serotonin
depletion via 5,7-DHT80. It is also important to note that
the present task did not measure positive emotions. While
ATD is associated with evoking negative biases2, con-
sistent with our results, future work will be required to
clarify whether positive emotions to social scenarios
would be blunted or potentiated by ATD. Another lim-
itation is that our study was reliant on self-reported
emotion. Future work could, for instance, seek to
understand how self-reported guilt evoked by the present
task may relate to a computational measure purported to
reflect guilt, estimated based on choice in behavioural
economic games37.
Our data from a novel test, that required drawing on
autobiographical memories to mentally simulate cued
social scenarios, demonstrate that there are important
individual differences in the way serotonin influences how
we react emotionally to social injustice. This should not
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come as a surprise given the intricacy of the serotonin
systems and the complexities of human emotion and
behaviour. While serotonin depletion potentiated the
magnitude of emotion nonspecifically at the group level,
personality traits played a critical role in shaping which
distinctive types of emotions were affected. There was a
qualitative dissociation in the way trait empathy, relative
to psychopathy, amplified social emotion following ser-
otonin depletion. Previous ATD studies on social cogni-
tion, by contrast, examined behavior rather than emotion
and found changes in the magnitude but not the quality of
effects5,6. We propose that traits in conjunction with the
memories our task evoked represent biological priors,
which prime individuals to have different emotional
reactions in the social world. Our data indicate serotonin
would affect the gain. Given emotions are a prescription
for action66, it follows that our results could represent
how serotonin impacts social behaviour via underlying
emotional responses, positioned at the nexus of a social
Pavlovian influence over action (Pavlovian action selec-
tion). When considering apparent paradoxes in the ser-
otonin literature2,46 and designing future studies, it is
critical to note that the quality and magnitude of effects of
a single serotonin manipulation can depend on person-
ality. These data additionally inform the neurochemical
basis of psychopathology associated with excessive emo-
tions such as guilt and shame. Our findings on the
interaction between the serotonin-depleted state and
personal attributes could help inform which individuals
are particularly vulnerable to pathological emotional
reactions, and who may be more amenable to serotonin-
modulating treatments, with implications for psychiatric
classification in frameworks such as the Research Domain
Criteria81.
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